Young Adult and Usual Adult Body Mass Index and Multiple Myeloma Risk: A Pooled Analysis in the International Multiple Myeloma Consortium (IMMC).
Identifieur interne : 000A71 ( PubMed/Corpus ); précédent : 000A70; suivant : 000A72Young Adult and Usual Adult Body Mass Index and Multiple Myeloma Risk: A Pooled Analysis in the International Multiple Myeloma Consortium (IMMC).
Auteurs : Brenda M. Birmann ; Gabriella Andreotti ; Anneclaire J. De Roos ; Nicola J. Camp ; Brian C H. Chiu ; John J. Spinelli ; Nikolaus Becker ; Véronique Benhaim-Luzon ; Parveen Bhatti ; Paolo Boffetta ; Paul Brennan ; Elizabeth E. Brown ; Pierluigi Cocco ; Laura Costas ; Wendy Cozen ; Silvia De Sanjosé ; Lenka Foretová ; Graham G. Giles ; Marc Maynadié ; Kirsten Moysich ; Alexandra Nieters ; Anthony Staines ; Guido Tricot ; Dennis Weisenburger ; Yawei Zhang ; Dalsu Baris ; Mark P. PurdueSource :
- Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [ 1538-7755 ] ; 2017.
Abstract
Background: Multiple myeloma risk increases with higher adult body mass index (BMI). Emerging evidence also supports an association of young adult BMI with multiple myeloma. We undertook a pooled analysis of eight case-control studies to further evaluate anthropometric multiple myeloma risk factors, including young adult BMI.Methods: We conducted multivariable logistic regression analysis of usual adult anthropometric measures of 2,318 multiple myeloma cases and 9,609 controls, and of young adult BMI (age 25 or 30 years) for 1,164 cases and 3,629 controls.Results: In the pooled sample, multiple myeloma risk was positively associated with usual adult BMI; risk increased 9% per 5-kg/m(2) increase in BMI [OR, 1.09; 95% confidence interval (CI), 1.04-1.14; P = 0.007]. We observed significant heterogeneity by study design (P = 0.04), noting the BMI-multiple myeloma association only for population-based studies (Ptrend = 0.0003). Young adult BMI was also positively associated with multiple myeloma (per 5-kg/m(2); OR, 1.2; 95% CI, 1.1-1.3; P = 0.0002). Furthermore, we observed strong evidence of interaction between younger and usual adult BMI (Pinteraction <0.0001); we noted statistically significant associations with multiple myeloma for persons overweight (25-<30 kg/m(2)) or obese (30+ kg/m(2)) in both younger and usual adulthood (vs. individuals consistently <25 kg/m(2)), but not for those overweight or obese at only one time period.Conclusions: BMI-associated increases in multiple myeloma risk were highest for individuals who were overweight or obese throughout adulthood.Impact: These findings provide the strongest evidence to date that earlier and later adult BMI may increase multiple myeloma risk and suggest that healthy BMI maintenance throughout life may confer an added benefit of multiple myeloma prevention. Cancer Epidemiol Biomarkers Prev; 26(6); 876-85. ©2017 AACR.
DOI: 10.1158/1055-9965.EPI-16-0762-T
PubMed: 28223430
Links to Exploration step
pubmed:28223430Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Young Adult and Usual Adult Body Mass Index and Multiple Myeloma Risk: A Pooled Analysis in the International Multiple Myeloma Consortium (IMMC).</title><author><name sortKey="Birmann, Brenda M" sort="Birmann, Brenda M" uniqKey="Birmann B" first="Brenda M" last="Birmann">Brenda M. Birmann</name><affiliation><nlm:affiliation>Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. brenda.birmann@channing.harvard.edu.</nlm:affiliation></affiliation></author><author><name sortKey="Andreotti, Gabriella" sort="Andreotti, Gabriella" uniqKey="Andreotti G" first="Gabriella" last="Andreotti">Gabriella Andreotti</name><affiliation><nlm:affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Rockville, Maryland.</nlm:affiliation></affiliation></author><author><name sortKey="De Roos, Anneclaire J" sort="De Roos, Anneclaire J" uniqKey="De Roos A" first="Anneclaire J" last="De Roos">Anneclaire J. De Roos</name><affiliation><nlm:affiliation>Department of Environmental and Occupational Health, Drexel University Dornsife School of Public Health, Philadelphia, Pennsylvania.</nlm:affiliation></affiliation></author><author><name sortKey="Camp, Nicola J" sort="Camp, Nicola J" uniqKey="Camp N" first="Nicola J" last="Camp">Nicola J. Camp</name><affiliation><nlm:affiliation>Division of Hematology and Hematologic Malignancies, University of Utah School of Medicine, Salt Lake City, Utah.</nlm:affiliation></affiliation></author><author><name sortKey="Chiu, Brian C H" sort="Chiu, Brian C H" uniqKey="Chiu B" first="Brian C H" last="Chiu">Brian C H. Chiu</name><affiliation><nlm:affiliation>Department of Health Studies, University of Chicago, Chicago, Illinois.</nlm:affiliation></affiliation></author><author><name sortKey="Spinelli, John J" sort="Spinelli, John J" uniqKey="Spinelli J" first="John J" last="Spinelli">John J. Spinelli</name><affiliation><nlm:affiliation>Cancer Control Research, BC Cancer Agency and School of Population and Public Health, University of British Columbia, Vancouver, British Coulmbia, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Becker, Nikolaus" sort="Becker, Nikolaus" uniqKey="Becker N" first="Nikolaus" last="Becker">Nikolaus Becker</name><affiliation><nlm:affiliation>German Cancer Center, Division of Cancer Epidemiology, Heidelberg, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Benhaim Luzon, Veronique" sort="Benhaim Luzon, Veronique" uniqKey="Benhaim Luzon V" first="Véronique" last="Benhaim-Luzon">Véronique Benhaim-Luzon</name><affiliation><nlm:affiliation>International Agency for Research on Cancer, Lyon, France.</nlm:affiliation></affiliation></author><author><name sortKey="Bhatti, Parveen" sort="Bhatti, Parveen" uniqKey="Bhatti P" first="Parveen" last="Bhatti">Parveen Bhatti</name><affiliation><nlm:affiliation>Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington.</nlm:affiliation></affiliation></author><author><name sortKey="Boffetta, Paolo" sort="Boffetta, Paolo" uniqKey="Boffetta P" first="Paolo" last="Boffetta">Paolo Boffetta</name><affiliation><nlm:affiliation>Mount Sinai School of Medicine, New York, New York.</nlm:affiliation></affiliation></author><author><name sortKey="Brennan, Paul" sort="Brennan, Paul" uniqKey="Brennan P" first="Paul" last="Brennan">Paul Brennan</name><affiliation><nlm:affiliation>International Agency for Research on Cancer, Lyon, France.</nlm:affiliation></affiliation></author><author><name sortKey="Brown, Elizabeth E" sort="Brown, Elizabeth E" uniqKey="Brown E" first="Elizabeth E" last="Brown">Elizabeth E. Brown</name><affiliation><nlm:affiliation>Department of Pathology and the Cancer Control and Population Sciences Program, UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama.</nlm:affiliation></affiliation></author><author><name sortKey="Cocco, Pierluigi" sort="Cocco, Pierluigi" uniqKey="Cocco P" first="Pierluigi" last="Cocco">Pierluigi Cocco</name><affiliation><nlm:affiliation>Department of Public Health, Occupational Health Section, University of Cagliari, Cagliari, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Costas, Laura" sort="Costas, Laura" uniqKey="Costas L" first="Laura" last="Costas">Laura Costas</name><affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Cozen, Wendy" sort="Cozen, Wendy" uniqKey="Cozen W" first="Wendy" last="Cozen">Wendy Cozen</name><affiliation><nlm:affiliation>Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.</nlm:affiliation></affiliation></author><author><name sortKey="De Sanjose, Silvia" sort="De Sanjose, Silvia" uniqKey="De Sanjose S" first="Silvia" last="De Sanjosé">Silvia De Sanjosé</name><affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Foretova, Lenka" sort="Foretova, Lenka" uniqKey="Foretova L" first="Lenka" last="Foretová">Lenka Foretová</name><affiliation><nlm:affiliation>Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.</nlm:affiliation></affiliation></author><author><name sortKey="Giles, Graham G" sort="Giles, Graham G" uniqKey="Giles G" first="Graham G" last="Giles">Graham G. Giles</name><affiliation><nlm:affiliation>Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Maynadie, Marc" sort="Maynadie, Marc" uniqKey="Maynadie M" first="Marc" last="Maynadié">Marc Maynadié</name><affiliation><nlm:affiliation>Registry of Hematological malignancies of Côte d'Or, University of Burgundy, and University Hospital, Dijon, France.</nlm:affiliation></affiliation></author><author><name sortKey="Moysich, Kirsten" sort="Moysich, Kirsten" uniqKey="Moysich K" first="Kirsten" last="Moysich">Kirsten Moysich</name><affiliation><nlm:affiliation>Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.</nlm:affiliation></affiliation></author><author><name sortKey="Nieters, Alexandra" sort="Nieters, Alexandra" uniqKey="Nieters A" first="Alexandra" last="Nieters">Alexandra Nieters</name><affiliation><nlm:affiliation>Center for Chronic Immunodeficiency, Faculty of Medicine, University of Freiburg, Freiburg, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Staines, Anthony" sort="Staines, Anthony" uniqKey="Staines A" first="Anthony" last="Staines">Anthony Staines</name><affiliation><nlm:affiliation>Ireland School of Nursing and Human Sciences, Dublin City University, Glasnevin, Dublin, Ireland.</nlm:affiliation></affiliation></author><author><name sortKey="Tricot, Guido" sort="Tricot, Guido" uniqKey="Tricot G" first="Guido" last="Tricot">Guido Tricot</name><affiliation><nlm:affiliation>Department of Internal Medicine, University of Iowa, Iowa City, Iowa.</nlm:affiliation></affiliation></author><author><name sortKey="Weisenburger, Dennis" sort="Weisenburger, Dennis" uniqKey="Weisenburger D" first="Dennis" last="Weisenburger">Dennis Weisenburger</name><affiliation><nlm:affiliation>Department of Pathology, City of Hope, Duarte, California.</nlm:affiliation></affiliation></author><author><name sortKey="Zhang, Yawei" sort="Zhang, Yawei" uniqKey="Zhang Y" first="Yawei" last="Zhang">Yawei Zhang</name><affiliation><nlm:affiliation>Department of Surgery, Yale School of Medicine, New Haven, Connecticut.</nlm:affiliation></affiliation></author><author><name sortKey="Baris, Dalsu" sort="Baris, Dalsu" uniqKey="Baris D" first="Dalsu" last="Baris">Dalsu Baris</name><affiliation><nlm:affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Rockville, Maryland.</nlm:affiliation></affiliation></author><author><name sortKey="Purdue, Mark P" sort="Purdue, Mark P" uniqKey="Purdue M" first="Mark P" last="Purdue">Mark P. Purdue</name><affiliation><nlm:affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Rockville, Maryland.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28223430</idno><idno type="pmid">28223430</idno><idno type="doi">10.1158/1055-9965.EPI-16-0762-T</idno><idno type="wicri:Area/PubMed/Corpus">000A71</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A71</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Young Adult and Usual Adult Body Mass Index and Multiple Myeloma Risk: A Pooled Analysis in the International Multiple Myeloma Consortium (IMMC).</title><author><name sortKey="Birmann, Brenda M" sort="Birmann, Brenda M" uniqKey="Birmann B" first="Brenda M" last="Birmann">Brenda M. Birmann</name><affiliation><nlm:affiliation>Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. brenda.birmann@channing.harvard.edu.</nlm:affiliation></affiliation></author><author><name sortKey="Andreotti, Gabriella" sort="Andreotti, Gabriella" uniqKey="Andreotti G" first="Gabriella" last="Andreotti">Gabriella Andreotti</name><affiliation><nlm:affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Rockville, Maryland.</nlm:affiliation></affiliation></author><author><name sortKey="De Roos, Anneclaire J" sort="De Roos, Anneclaire J" uniqKey="De Roos A" first="Anneclaire J" last="De Roos">Anneclaire J. De Roos</name><affiliation><nlm:affiliation>Department of Environmental and Occupational Health, Drexel University Dornsife School of Public Health, Philadelphia, Pennsylvania.</nlm:affiliation></affiliation></author><author><name sortKey="Camp, Nicola J" sort="Camp, Nicola J" uniqKey="Camp N" first="Nicola J" last="Camp">Nicola J. Camp</name><affiliation><nlm:affiliation>Division of Hematology and Hematologic Malignancies, University of Utah School of Medicine, Salt Lake City, Utah.</nlm:affiliation></affiliation></author><author><name sortKey="Chiu, Brian C H" sort="Chiu, Brian C H" uniqKey="Chiu B" first="Brian C H" last="Chiu">Brian C H. Chiu</name><affiliation><nlm:affiliation>Department of Health Studies, University of Chicago, Chicago, Illinois.</nlm:affiliation></affiliation></author><author><name sortKey="Spinelli, John J" sort="Spinelli, John J" uniqKey="Spinelli J" first="John J" last="Spinelli">John J. Spinelli</name><affiliation><nlm:affiliation>Cancer Control Research, BC Cancer Agency and School of Population and Public Health, University of British Columbia, Vancouver, British Coulmbia, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Becker, Nikolaus" sort="Becker, Nikolaus" uniqKey="Becker N" first="Nikolaus" last="Becker">Nikolaus Becker</name><affiliation><nlm:affiliation>German Cancer Center, Division of Cancer Epidemiology, Heidelberg, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Benhaim Luzon, Veronique" sort="Benhaim Luzon, Veronique" uniqKey="Benhaim Luzon V" first="Véronique" last="Benhaim-Luzon">Véronique Benhaim-Luzon</name><affiliation><nlm:affiliation>International Agency for Research on Cancer, Lyon, France.</nlm:affiliation></affiliation></author><author><name sortKey="Bhatti, Parveen" sort="Bhatti, Parveen" uniqKey="Bhatti P" first="Parveen" last="Bhatti">Parveen Bhatti</name><affiliation><nlm:affiliation>Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington.</nlm:affiliation></affiliation></author><author><name sortKey="Boffetta, Paolo" sort="Boffetta, Paolo" uniqKey="Boffetta P" first="Paolo" last="Boffetta">Paolo Boffetta</name><affiliation><nlm:affiliation>Mount Sinai School of Medicine, New York, New York.</nlm:affiliation></affiliation></author><author><name sortKey="Brennan, Paul" sort="Brennan, Paul" uniqKey="Brennan P" first="Paul" last="Brennan">Paul Brennan</name><affiliation><nlm:affiliation>International Agency for Research on Cancer, Lyon, France.</nlm:affiliation></affiliation></author><author><name sortKey="Brown, Elizabeth E" sort="Brown, Elizabeth E" uniqKey="Brown E" first="Elizabeth E" last="Brown">Elizabeth E. Brown</name><affiliation><nlm:affiliation>Department of Pathology and the Cancer Control and Population Sciences Program, UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama.</nlm:affiliation></affiliation></author><author><name sortKey="Cocco, Pierluigi" sort="Cocco, Pierluigi" uniqKey="Cocco P" first="Pierluigi" last="Cocco">Pierluigi Cocco</name><affiliation><nlm:affiliation>Department of Public Health, Occupational Health Section, University of Cagliari, Cagliari, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Costas, Laura" sort="Costas, Laura" uniqKey="Costas L" first="Laura" last="Costas">Laura Costas</name><affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Cozen, Wendy" sort="Cozen, Wendy" uniqKey="Cozen W" first="Wendy" last="Cozen">Wendy Cozen</name><affiliation><nlm:affiliation>Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.</nlm:affiliation></affiliation></author><author><name sortKey="De Sanjose, Silvia" sort="De Sanjose, Silvia" uniqKey="De Sanjose S" first="Silvia" last="De Sanjosé">Silvia De Sanjosé</name><affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Foretova, Lenka" sort="Foretova, Lenka" uniqKey="Foretova L" first="Lenka" last="Foretová">Lenka Foretová</name><affiliation><nlm:affiliation>Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.</nlm:affiliation></affiliation></author><author><name sortKey="Giles, Graham G" sort="Giles, Graham G" uniqKey="Giles G" first="Graham G" last="Giles">Graham G. Giles</name><affiliation><nlm:affiliation>Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Maynadie, Marc" sort="Maynadie, Marc" uniqKey="Maynadie M" first="Marc" last="Maynadié">Marc Maynadié</name><affiliation><nlm:affiliation>Registry of Hematological malignancies of Côte d'Or, University of Burgundy, and University Hospital, Dijon, France.</nlm:affiliation></affiliation></author><author><name sortKey="Moysich, Kirsten" sort="Moysich, Kirsten" uniqKey="Moysich K" first="Kirsten" last="Moysich">Kirsten Moysich</name><affiliation><nlm:affiliation>Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.</nlm:affiliation></affiliation></author><author><name sortKey="Nieters, Alexandra" sort="Nieters, Alexandra" uniqKey="Nieters A" first="Alexandra" last="Nieters">Alexandra Nieters</name><affiliation><nlm:affiliation>Center for Chronic Immunodeficiency, Faculty of Medicine, University of Freiburg, Freiburg, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Staines, Anthony" sort="Staines, Anthony" uniqKey="Staines A" first="Anthony" last="Staines">Anthony Staines</name><affiliation><nlm:affiliation>Ireland School of Nursing and Human Sciences, Dublin City University, Glasnevin, Dublin, Ireland.</nlm:affiliation></affiliation></author><author><name sortKey="Tricot, Guido" sort="Tricot, Guido" uniqKey="Tricot G" first="Guido" last="Tricot">Guido Tricot</name><affiliation><nlm:affiliation>Department of Internal Medicine, University of Iowa, Iowa City, Iowa.</nlm:affiliation></affiliation></author><author><name sortKey="Weisenburger, Dennis" sort="Weisenburger, Dennis" uniqKey="Weisenburger D" first="Dennis" last="Weisenburger">Dennis Weisenburger</name><affiliation><nlm:affiliation>Department of Pathology, City of Hope, Duarte, California.</nlm:affiliation></affiliation></author><author><name sortKey="Zhang, Yawei" sort="Zhang, Yawei" uniqKey="Zhang Y" first="Yawei" last="Zhang">Yawei Zhang</name><affiliation><nlm:affiliation>Department of Surgery, Yale School of Medicine, New Haven, Connecticut.</nlm:affiliation></affiliation></author><author><name sortKey="Baris, Dalsu" sort="Baris, Dalsu" uniqKey="Baris D" first="Dalsu" last="Baris">Dalsu Baris</name><affiliation><nlm:affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Rockville, Maryland.</nlm:affiliation></affiliation></author><author><name sortKey="Purdue, Mark P" sort="Purdue, Mark P" uniqKey="Purdue M" first="Mark P" last="Purdue">Mark P. Purdue</name><affiliation><nlm:affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Rockville, Maryland.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</title><idno type="eISSN">1538-7755</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background: Multiple myeloma risk increases with higher adult body mass index (BMI). Emerging evidence also supports an association of young adult BMI with multiple myeloma. We undertook a pooled analysis of eight case-control studies to further evaluate anthropometric multiple myeloma risk factors, including young adult BMI.Methods: We conducted multivariable logistic regression analysis of usual adult anthropometric measures of 2,318 multiple myeloma cases and 9,609 controls, and of young adult BMI (age 25 or 30 years) for 1,164 cases and 3,629 controls.Results: In the pooled sample, multiple myeloma risk was positively associated with usual adult BMI; risk increased 9% per 5-kg/m(2) increase in BMI [OR, 1.09; 95% confidence interval (CI), 1.04-1.14; P = 0.007]. We observed significant heterogeneity by study design (P = 0.04), noting the BMI-multiple myeloma association only for population-based studies (Ptrend = 0.0003). Young adult BMI was also positively associated with multiple myeloma (per 5-kg/m(2); OR, 1.2; 95% CI, 1.1-1.3; P = 0.0002). Furthermore, we observed strong evidence of interaction between younger and usual adult BMI (Pinteraction <0.0001); we noted statistically significant associations with multiple myeloma for persons overweight (25-<30 kg/m(2)) or obese (30+ kg/m(2)) in both younger and usual adulthood (vs. individuals consistently <25 kg/m(2)), but not for those overweight or obese at only one time period.Conclusions: BMI-associated increases in multiple myeloma risk were highest for individuals who were overweight or obese throughout adulthood.Impact: These findings provide the strongest evidence to date that earlier and later adult BMI may increase multiple myeloma risk and suggest that healthy BMI maintenance throughout life may confer an added benefit of multiple myeloma prevention. Cancer Epidemiol Biomarkers Prev; 26(6); 876-85. ©2017 AACR.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">28223430</PMID><DateCreated><Year>2017</Year><Month>02</Month><Day>22</Day></DateCreated><DateRevised><Year>2017</Year><Month>06</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7755</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</Title><ISOAbbreviation>Cancer Epidemiol. Biomarkers Prev.</ISOAbbreviation></Journal><ArticleTitle>Young Adult and Usual Adult Body Mass Index and Multiple Myeloma Risk: A Pooled Analysis in the International Multiple Myeloma Consortium (IMMC).</ArticleTitle><Pagination><MedlinePgn>876-885</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1158/1055-9965.EPI-16-0762-T</ELocationID><Abstract><AbstractText>Background: Multiple myeloma risk increases with higher adult body mass index (BMI). Emerging evidence also supports an association of young adult BMI with multiple myeloma. We undertook a pooled analysis of eight case-control studies to further evaluate anthropometric multiple myeloma risk factors, including young adult BMI.Methods: We conducted multivariable logistic regression analysis of usual adult anthropometric measures of 2,318 multiple myeloma cases and 9,609 controls, and of young adult BMI (age 25 or 30 years) for 1,164 cases and 3,629 controls.Results: In the pooled sample, multiple myeloma risk was positively associated with usual adult BMI; risk increased 9% per 5-kg/m(2) increase in BMI [OR, 1.09; 95% confidence interval (CI), 1.04-1.14; P = 0.007]. We observed significant heterogeneity by study design (P = 0.04), noting the BMI-multiple myeloma association only for population-based studies (Ptrend = 0.0003). Young adult BMI was also positively associated with multiple myeloma (per 5-kg/m(2); OR, 1.2; 95% CI, 1.1-1.3; P = 0.0002). Furthermore, we observed strong evidence of interaction between younger and usual adult BMI (Pinteraction <0.0001); we noted statistically significant associations with multiple myeloma for persons overweight (25-<30 kg/m(2)) or obese (30+ kg/m(2)) in both younger and usual adulthood (vs. individuals consistently <25 kg/m(2)), but not for those overweight or obese at only one time period.Conclusions: BMI-associated increases in multiple myeloma risk were highest for individuals who were overweight or obese throughout adulthood.Impact: These findings provide the strongest evidence to date that earlier and later adult BMI may increase multiple myeloma risk and suggest that healthy BMI maintenance throughout life may confer an added benefit of multiple myeloma prevention. Cancer Epidemiol Biomarkers Prev; 26(6); 876-85. ©2017 AACR.</AbstractText><CopyrightInformation>©2017 American Association for Cancer Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Birmann</LastName><ForeName>Brenda M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. brenda.birmann@channing.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreotti</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Rockville, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Roos</LastName><ForeName>Anneclaire J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Environmental and Occupational Health, Drexel University Dornsife School of Public Health, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camp</LastName><ForeName>Nicola J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Division of Hematology and Hematologic Malignancies, University of Utah School of Medicine, Salt Lake City, Utah.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiu</LastName><ForeName>Brian C H</ForeName><Initials>BCH</Initials><AffiliationInfo><Affiliation>Department of Health Studies, University of Chicago, Chicago, Illinois.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spinelli</LastName><ForeName>John J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Cancer Control Research, BC Cancer Agency and School of Population and Public Health, University of British Columbia, Vancouver, British Coulmbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becker</LastName><ForeName>Nikolaus</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>German Cancer Center, Division of Cancer Epidemiology, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benhaim-Luzon</LastName><ForeName>Véronique</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>International Agency for Research on Cancer, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatti</LastName><ForeName>Parveen</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boffetta</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Mount Sinai School of Medicine, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Prevention Research Institute, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brennan</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>International Agency for Research on Cancer, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Elizabeth E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Department of Pathology and the Cancer Control and Population Sciences Program, UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cocco</LastName><ForeName>Pierluigi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Public Health, Occupational Health Section, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costas</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cozen</LastName><ForeName>Wendy</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Sanjosé</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foretová</LastName><ForeName>Lenka</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giles</LastName><ForeName>Graham G</ForeName><Initials>GG</Initials><AffiliationInfo><Affiliation>Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maynadié</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Registry of Hematological malignancies of Côte d'Or, University of Burgundy, and University Hospital, Dijon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moysich</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieters</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Chronic Immunodeficiency, Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Staines</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ireland School of Nursing and Human Sciences, Dublin City University, Glasnevin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tricot</LastName><ForeName>Guido</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Iowa, Iowa City, Iowa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weisenburger</LastName><ForeName>Dennis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pathology, City of Hope, Duarte, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yawei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Surgery, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baris</LastName><ForeName>Dalsu</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Rockville, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Purdue</LastName><ForeName>Mark P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Rockville, Maryland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K07 CA115687</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R13 CA159842</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA014089</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 CA198239</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA127435</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA149445</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA042014</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cancer Epidemiol Biomarkers Prev</MedlineTA><NlmUniqueID>9200608</NlmUniqueID><ISSNLinking>1055-9965</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2016 Apr 1;76(7):1935-41</RefSource><PMID Version="1">26921332</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2000 Oct 15;96(8):2856-61</RefSource><PMID Version="1">11023522</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 1987 Dec;126(6):1051-62</RefSource><PMID Version="1">3687917</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Public Health. 1992 Jul;82(7):990-7</RefSource><PMID Version="1">1609918</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1415-21</RefSource><PMID Version="1">15342441</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2009 May 28;113(22):5412-7</RefSource><PMID Version="1">19179464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2003 Apr 24;348(17):1625-38</RefSource><PMID Version="1">12711737</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2342-7</RefSource><PMID Version="1">17132770</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncologist. 2010;15(10):1083-101</RefSource><PMID Version="1">20930095</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Haematologica. 2008 Nov;93(11):1666-77</RefSource><PMID Version="1">18835833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Causes Control. 2010 Feb;21(2):223-36</RefSource><PMID Version="1">19851877</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2013 Apr 15;177(8):776-86</RefSource><PMID Version="1">23543160</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncologist. 2011;16(11):1600-3</RefSource><PMID Version="1">21968047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2010 Nov;24(11):1940-50</RefSource><PMID Version="1">20844560</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leuk Lymphoma. 2013 Jun;54(6):1221-7</RefSource><PMID Version="1">23098244</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2012 Nov 22;120(22):4418-20</RefSource><PMID Version="1">23007407</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2009 Oct;23(10):1691-7</RefSource><PMID Version="1">19587704</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2009 Aug 1;170(3):297-307</RefSource><PMID Version="1">19478235</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Epidemiology. 2010 Mar;21(2):272-3</RefSource><PMID Version="1">20160567</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Epidemiology. 2005 Sep;16(5):691-4</RefSource><PMID Version="1">16135948</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2009 May 28;113(22):5418-22</RefSource><PMID Version="1">19234139</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Causes Control. 2001 Feb;12(2):117-25</RefSource><PMID Version="1">11246840</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2011 Nov 24;118(22):5872-82</RefSource><PMID Version="1">21908434</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Causes Control. 2004 May;15(4):419-28</RefSource><PMID Version="1">15141141</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2008 Feb 16;371(9612):569-78</RefSource><PMID Version="1">18280327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2010 Apr 29;115(17 ):3541-52</RefSource><PMID Version="1">20053756</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World Health Organ Tech Rep Ser. 1995;854:1-452</RefSource><PMID Version="1">8594834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2010 Aug 19;116(7):1056-9</RefSource><PMID Version="1">20421448</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leuk Res. 2004 Jul;28(7):713-24</RefSource><PMID Version="1">15158093</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1620-7</RefSource><PMID Version="1">23964064</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2012 Dec 13;120(25):4929-37</RefSource><PMID Version="1">23074271</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2011 Jul;47(11):1606-15</RefSource><PMID Version="1">21354783</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2007 Dec 1;121(11):2512-6</RefSource><PMID Version="1">17680557</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cell Cloning. 1991 May;9(3):166-84</RefSource><PMID Version="1">2061619</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2010 Jun 15;171(12):1270-81</RefSource><PMID Version="1">20494998</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Causes Control. 2013 Jul;24(7):1279-89</RefSource><PMID Version="1">23568533</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Haematol. 2013 Oct;163(1):40-6</RefSource><PMID Version="1">23889344</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2002 Jun 1;99(11):4138-46</RefSource><PMID Version="1">12010818</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Obes. 2013;2013:291546</RefSource><PMID Version="1">24073332</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2015 Feb;29(2):507-10</RefSource><PMID Version="1">25287992</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Haematol. 2014 Sep;166(5):667-76</RefSource><PMID Version="1">24861847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30</RefSource><PMID Version="1">26742998</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):921-5</RefSource><PMID Version="1">16702371</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):631-4</RefSource><PMID Version="1">25538226</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2009 Jul 23;114(4):791-5</RefSource><PMID Version="1">19182202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leuk Res. 2007 Apr;31(4):547-51</RefSource><PMID Version="1">16962170</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>09</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>01</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>01</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>06</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28223430</ArticleId><ArticleId IdType="pii">1055-9965.EPI-16-0762-T</ArticleId><ArticleId IdType="doi">10.1158/1055-9965.EPI-16-0762-T</ArticleId><ArticleId IdType="pmc">PMC5457306</ArticleId><ArticleId IdType="mid">NIHMS853114</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A71 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000A71 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:28223430
|texte= Young Adult and Usual Adult Body Mass Index and Multiple Myeloma Risk: A Pooled Analysis in the International Multiple Myeloma Consortium (IMMC).
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:28223430" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |